Circulating adrenomedullin is increased in relation with increased creatinine and atrial natriuretic peptide in liver-transplant recipients

Regulatory Peptides

Volumn 114, Issue 1, 2003, Pages 61-66

  Geny, Bernard ^a   Ellero, Bernard ^b   Charloux, Anne ^a   Brandenberger, Gabrielle ^a   Doutreleau, Stéphane ^a   Piquard, François ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Adrenomedullin; Atrial natriuretic peptide; Liver; Transplantation

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; CREATININE; CYCLOSPORIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; HEART RATE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; PATIENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REST; SUPINE POSITION; SYSTEMIC CIRCULATION; VENOUS BLOOD;

EID: 0037727628     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00106-X     Document Type: Article

References (35)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H.et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
2. Marinoni E., Di Iorio R., Letizia C., Lucchini C., Alo P., Cosmi E.V. Changes in plasma adrenomedullin levels during the menstrual cycle. Regul. Pept. 87:2000;15-18.
3. Letizia C., Cerci S., Centanni M., De Toma G., Subioli S., Scuro L.et al. Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment. Clin. Endocrinol. 48:1998;145-148.
4. Taniyama M., Kitamura K., Ban Y., Sugita E., Ito K., Katagiri T. Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis. Clin. Endocrinol. 46:1997;271-274.
5. Fabrega E., Casafont F., Crespo J., de la Pena J., San Miguel G., de las Heras G.et al. Plasma adrenomedullin levels in patients with hepatic cirrhosis. Am. J. Gastroenterol. 92:1997;1901-1934.
6. Eto T., Kitamura K. Adrenomedullin and its role in renal disease. Nephron. 89:2001;121-134.
7. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21:2000;138-167.
8. Richards A.M., Nicholls M.G., Lewis L., Lainchbury J.G. Adrenomedullin. Clin. Sci. 91:1996;3-16.
9. Genesca J., Gonzalez A., Catalan R., Segura R., Martinez M., Esteban R.et al. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis. Dig. Dis. Sci. 44:1999;372-376.
10. Guevara M., Gines P., Jimenez W., Sort P., Fernandez-Esparrach G., Escorsell A.et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology. 114:1998;336-343.
11. Kojima H., Tsujimoto T., Uemura M., Takaya A., Okamoto S., Ueda S.et al. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis. J. Hepatol. 28:1998;840-846.
12. Geny B., Brandenberger G., Lonsdorfer J., Chakfé N., Haberey P., Piquard F. Circulating adrenomedullin is increased after heart transplantation. Cardiovasc. Res. 41:1999;731-736.
13. Piquard F., Charloux A., Mettauer B., Epailly E., Lonsdorfer E., Popescu S.et al. Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipients. J. Clin. Endocrinol. Metab. 85:2000;2828-2831.
14. Fabrega E., Crespo J., Casafont F., de La Pena J., Garcia-Unzueta M.T., Amado J.A.et al. Adrenomedullin in liver transplantation and its relationship with vascular complications. Liver Transpl. Surg. 5:1999;485-490.
15. Handelsman D.J., Strasser S., McDonald J.A., Conway A.J., McCaughan G.W. Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clin. Endocrinol. 43:1995;331-337.
16. Madersbacher S., Ludvik G., Stulnig T., Grunberger T., Maier U. The impact of liver transplantation on endocrine status in men. Clin. Endocrinol. 44:1996;461-466.
17. Berg U.B., Ericzon B.G., Nemeth A. Renal function before and long after liver transplantation in children. Transplantation. 72:2001;631-637.
18. Gonwa T.A. Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transpl. 7:2001;S22-S26.
19. Rabkin J.M., Corless C.L., Rosen H.R., Olyaei A.J. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am. J. Surg. 183:2002;595-599.
20. Lawless S., Ellis D., Thompson A., Cook D.R., Esquivel C., Starzl T. Mechanisms of hypertension during and after orthotopic liver transplantation in children. J. Pediatr. 115:1989;372-379.
21. Nishimori T., Tsujino M., Sato K., Imai T., Marumo F., Hirata Y. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J. Mol. Cell. Cardiol. 29:1997;2125-2130.
22. Brenner B.M., Ballermann B.J., Gunning M.E., Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70:1990;665-699.
23. Cillo U., Bassanello M., Lancerin F., Senzolo M., Burra P., Brolese A.et al. Physiological and clinical implications of pro-ANP (1-98) circulating levels in the perioperative phase of liver transplantation. Clin. Chim. Acta. 310:2001;39-48.
24. Vesely D.L., Blankenship M., Douglass M.A., McCormick M.T., Rodriguez-Paz G., Schocken D.D. Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans. Life Sci. 59:1996;243-254.
25. Franz M., Woloszczuk W., Hörl W.H. N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients. Transplantation. 72:2001;89-94.
26. Piccinni P., Rossaro L., Graziotto A., Tripepi A., Meneghetti L., Inturri P.et al. Human natriuretic factor in cirrhotic patients undergoing orthotopic liver transplantation. Transpl. Int. 8:1995;51-54.
27. Braith R.W., Mills R.M., Wilcox C.S. Fluid homeostasis after heart transplantation: the role of cardiac denervation. J. Heart Lung Transpl. 15:1996;872-880.
28. Piquard F., Geny B., Ellero B., Canguilhem B., Mettauer B., Epailly E.et al. Role of the immunosuppressive therapy in neuroendocrine activation after human heart, renal and liver transplantation. Transplant. Proc. 30:1998;2124-2126.
29. Nishikimi T., Kitamura K., Saito Y., Shimada K., Ishimitsu T., Takamiya M.et al. Clinical studies for the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension. 24:1994;600-604.
30. Yoshibayashi M., Kamiya T., Kitamura K., Saito Y., Kangawa K., Nishikimi T.et al. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age. Am. J. Cardiol. 79:1997;1556-1558.
31. DeGasperi A., Cristalli A., Corti A., Fantini G., Colussi G., Prosperi M.et al. Changes in circulating levels of atrial natriuretic factor (ANF) during orthotopic liver transplantation in humans. Transpl. Int. 7:1994;S134-S138.
32. Piquard F., Richard R., Hardy H., Doutreleau S., Charloux A., Brandenberger G.et al. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart-transplant patients. J. Appl. Physiol. 93:2002;569-575.
33. Geny B., Hardy H., Lampert E., Charloux A., Charpentier A., Lonsdorfer J.et al. Short term effect of cyclosporine on circulating adrenomedullin after heart transplantation. J. Thorac. Cardiovasc. Surg. 117:1999;391-392.
34. Kohno M., Kano H., Horio T., Yokokawa K., Yasunari K., Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension. 25:1995;1186-1190.
35. Eto T., Kitamura K., Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin. Exp. Pharmacol. Physiol. 26:1999;371-380.